Abstract
Human papilloma virus (HPV)-related squamous cell carcinoma (SCC) is biologically unique and has a better prognosis than conventional SCC of the head and neck. p16 immunohistochemistry emerged as a valuable surrogate marker for HPV in oropharyngeal SCC. The criteria for a positive p16 result in tissue specimens are well established. However, there is no consensus regarding interpreting p16 staining in cell blocks and other cytology specimens. This review discusses the current evidence on p16 testing in cytology specimens and also highlights other methods for HPV testing, including DNA and RNA in situ hybridization, as well as other molecular HPV tests.
References
1.
zur Hausen
H
. Condylomata acuminata and human genital cancer
. Cancer Res
. 1976
Feb
;36
(2 pt 2
):794
.
[PubMed]
0008-54722.
El-Mofty
SK
, Patil
S
. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype
. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
. 2006
Mar
;101
(3
):339
–45
.
[PubMed]
1079-21043.
Chaturvedi
AK
, Engels
EA
, Anderson
WF
, Gillison
ML
. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States
. J Clin Oncol
. 2008
Feb
;26
(4
):612
–9
.
[PubMed]
0732-183X4.
Westra
WH
. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer
. Head Neck Pathol
. 2009
Mar
;3
(1
):78
–81
.
[PubMed]
1936-055X5.
Marur
S
, D’Souza
G
, Westra
WH
, Forastiere
AA
. HPV-associated head and neck cancer: a virus-related cancer epidemic
. Lancet Oncol
. 2010
Aug
;11
(8
):781
–9
.
[PubMed]
1470-20456.
Chaturvedi
AK
, Engels
EA
, Pfeiffer
RM
, Hernandez
BY
, Xiao
W
, Kim
E
, et al Human papillomavirus and rising oropharyngeal cancer incidence in the United States
. J Clin Oncol
. 2011
Nov
;29
(32
):4294
–301
.
[PubMed]
0732-183X7.
Singhi
AD
, Califano
J
, Westra
WH
. High-risk human papillomavirus in nasopharyngeal carcinoma
. Head Neck
. 2012
Feb
;34
(2
):213
–8
.
[PubMed]
1043-30748.
Bishop
JA
, Andreasen
S
, Hang
JF
, Bullock
MJ
, Chen
TY
, Franchi
A
, et al HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features
. Am J Surg Pathol
. 2017
Dec
;41
(12
):1690
–701
.
[PubMed]
0147-51859.
Chernock
RD
, El-Mofty
SK
, Thorstad
WL
, Parvin
CA
, Lewis
JS
Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome
. Head Neck Pathol
. 2009
Sep
;3
(3
):186
–94
.
[PubMed]
1936-055X10.
Lewis
JS
Jr, Khan
RA
, Masand
RP
, Chernock
RD
, Zhang
Q
, Al-Naief
NS
, et al Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study
. Histopathology
. 2012
Feb
;60
(3
):427
–36
.
[PubMed]
0309-016711.
Gondim
DD
, Haynes
W
, Wang
X
, Chernock
RD
, El-Mofty
SK
, Lewis
JS
Jr. Histologic typing in oropharyngeal squamous cell carcinoma
. Am J Surg Pathol
. 2016
Aug
;40
(8
):1117
–24
.
[PubMed]
0147-518512.
Lewis
JS
Jr. p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma
. Head Neck Pathol
. 2012
Jul
;6
(1
Suppl 1
):S75
–82
.
[PubMed]
1936-055X13.
Lewis
JS
Jr, Beadle
B
, Bishop
JA
, Chernock
RD
, Colasacco
C
, Lacchetti
C
, et al Human papillomavirus testing in head and neck carcinomas: Guideline from the College of American Pathologists
. Arch Pathol Lab Med
. 2018
May
;142
(5
):559
–97
.
[PubMed]
0003-998514.
McIlwain
WR
, Sood
AJ
, Nguyen
SA
, Day
TA
. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer
. JAMA Otolaryngol Head Neck Surg
. 2014
May
;140
(5
):441
–7
.
[PubMed]
2168-618115.
Begum
S
, Gillison
ML
, Nicol
TL
, Westra
WH
. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck
. Clin Cancer Res
. 2007
Feb
;13
(4
):1186
–91
.
[PubMed]
1078-043216.
Holmes
BJ
, Maleki
Z
, Westra
WH
. The fidelity of p16 staining as a surrogate marker of human papillomavirus status in fine-needle aspirates and core biopsies of neck node metastases: implications for HPV testing protocols
. Acta Cytol
. 2015
;59
(1
):97
–103
.
[PubMed]
0001-554717.
Jalaly
JB
, Lewis
JS
Jr, Collins
BT
, Wu
X
, Ma
XJ
, Luo
Y
, et al Correlation of p16 immunohistochemistry in FNA biopsies with corresponding tissue specimens in HPV-related squamous cell carcinomas of the oropharynx
. Cancer Cytopathol
. 2015
Dec
;123
(12
):723
–31
.
[PubMed]
1934-662X18.
Xu
B
, Ghossein
R
, Lane
J
, Lin
O
, Katabi
N
. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma
. Hum Pathol
. 2016
Aug
;54
:193
–200
.
[PubMed]
0046-817719.
Allison
DB
, Miller
JA
, Coquia
SF
, Maleki
Z
. Ultrasonography-guided fine-needle aspiration with concurrent small core biopsy of neck masses and lymph nodes yields adequate material for HPV testing in head and neck squamous cell carcinomas
. J Am Soc Cytopathol
. 2016
Jan
;5
(1
):22
–30
. 2213-294520.
Segura
SE
, Lajara
S
, Jacob
J
, Khader
SN
, Hakima
L
. Correlation of P16 Expression in Fine Needle Aspiration Cytology and Corresponding Histopathology in Head and Neck Squamous Cell Carcinomas. In MODERN PATHOLOGY 2018
Mar 1 (Vol. 31, pp. 173-174). 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA: NATURE PUBLISHING GROUP.21.
Grimes
R
, Garcia-Buitrago
MT
, Jorda
M
, Ganjei-Azar
P
, Ferrell
A
, Gomez-Fernandez
C
. p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma
. Acta Cytol
. 2013
;57
(1
):33
–7
.
[PubMed]
0001-554722.
Jakscha
J
, Zlobec
I
, Storck
C
, Obermann
EC
, Tornillo
L
, Terracciano
LM
, et al The clinical impact of p16 status in fine-needle aspirates of cervical lymph node metastasis of head and neck squamous cell carcinomas
. Eur Arch Otorhinolaryngol
. 2013
Feb
;270
(2
):661
–7
.
[PubMed]
0937-447723.
Huang
CC
, Qiu
JT
, Kashima
ML
, Kurman
RJ
, Wu
TC
. Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Modern pathology: an official journal of the United States and Canadian Academy of Pathology
. Inc.
1998
Oct
;11
(10
):971
–7
.24.
Ukpo
OC
, Flanagan
JJ
, Ma
XJ
, Luo
Y
, Thorstad
WL
, Lewis
JS
Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma
. Am J Surg Pathol
. 2011
Sep
;35
(9
):1343
–50
.
[PubMed]
0147-518525.
Bishop
JA
, Ma
XJ
, Wang
H
, Luo
Y
, Illei
PB
, Begum
S
, et al Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method
. Am J Surg Pathol
. 2012
Dec
;36
(12
):1874
–82
.
[PubMed]
0147-518526.
Jannapureddy
S
, Cohen
C
, Lau
S
, Beitler
JJ
, Siddiqui
MT
. Assessing for primary oropharyngeal or nasopharyngeal squamous cell carcinoma from fine needle aspiration of cervical lymph node metastases
. Diagn Cytopathol
. 2010
Nov
;38
(11
):795
–800
.
[PubMed]
8755-103927.
Hou
Y
, Chaudhary
S
, Shen
R
, Li
Z
. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas
. Diagn Cytopathol
. 2016
Oct
;44
(10
):792
–8
.
[PubMed]
8755-103928.
Lewis
JS
Jr, Thorstad
WL
, Chernock
RD
, Haughey
BH
, Yip
JH
, Zhang
Q
, et al p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status
. Am J Surg Pathol
. 2010
Aug
;34
(8
):1088
–96
.
[PubMed]
0147-518529.
de Roda Husman
AM
, Walboomers
JM
, van den Brule
AJ
, Meijer
CJ
, Snijders
PJ
. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR
. J Gen Virol
. 1995
Apr
;76
(Pt 4
):1057
–62
.
[PubMed]
0022-131730.
Jacobs
MV
, Snijders
PJ
, Helmerhorst
TJ
, Meijer
J
, Walboomers
JM
. PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical A General Primer GP5 ϩ / GP6 ϩ -Mediated PCR-Enzyme Immunoassay Method for Rapid Detection of 14 High-Risk and 6 Low-Risk Human Pap
. J Clin Microbiol
. 1997
;35
:791
.
[PubMed]
0095-113731.
Channir
HI
, Grønhøj Larsen
C
, Ahlborn
LB
, van Overeem Hansen
T
, Gerds
TA
, Charabi
BW
, et al Validation study of HPV DNA detection from stained FNA smears by polymerase chain reaction: improving the diagnostic workup of patients with a tumor on the neck
. Cancer Cytopathol
. 2016
Nov
;124
(11
):820
–7
.
[PubMed]
1934-662X32.
Sivars
L
, Landin
D
, Haeggblom
L
, Tertipis
N
, Grün
N
, Bersani
C
, et al Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study
. Head Neck
. 2017
Mar
;39
(3
):419
–26
.
[PubMed]
1043-307433.
Poljak
M
, Brencic
A
, Seme
K
, Vince
A
, Marin
IJ
. Comparative evaluation of first- and second-generation digene hybrid capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer
. J Clin Microbiol
. 1999
Mar
;37
(3
):796
–7
.
[PubMed]
0095-113734.
Schiffman
M
, Wheeler
CM
, Dasgupta
A
, Solomon
D
, Castle
PE
; ALTS Group
. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal papanicolaou smears
. Am J Clin Pathol
. 2005
Nov
;124
(5
):722
–32
.
[PubMed]
0002-917335.
Bishop
JA
, Maleki
Z
, Valsamakis
A
, Ogawa
T
, Chang
X
, Pai
SI
, et al Application of the hybrid capture 2 assay to squamous cell carcinomas of the head and neck: a convenient liquid-phase approach for the reliable determination of human papillomavirus status
. Cancer Cytopathol
. 2012
Feb
;120
(1
):18
–25
.
[PubMed]
1934-662X36.
Smith
DF
, Maleki
Z
, Coughlan
D
, Gooi
Z
, Akpeng
B
, Ogawa
T
, et al Human papillomavirus status of head and neck cancer as determined in cytologic specimens using the hybrid-capture 2 assay
. Oral Oncol
. 2014
Jun
;50
(6
):600
–4
.
[PubMed]
1368-837537.
Rao
A
, Young
S
, Erlich
H
, Boyle
S
, Krevolin
M
, Sun
R
, et al Development and characterization of the cobas human papillomavirus test
. J Clin Microbiol
. 2013
May
;51
(5
):1478
–84
.
[PubMed]
0095-113738.
Kerr
DA
, Pitman
MB
, Sweeney
B
, Arpin
RN
3rd, Wilbur
DC
, Faquin
WC
. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck
. Cancer Cytopathol
. 2014
Mar
;122
(3
):167
–74
.
[PubMed]
1934-662X39.
Baldassarri
R
, Aronberg
R
, Levi
AW
, Yarbrough
WG
, Kowalski
D
, Chhieng
D
. Detection and genotype of high-risk human papillomavirus in fine-needle aspirates of patients with metastatic squamous cell carcinoma is helpful in determining tumor origin
. Am J Clin Pathol
. 2015
May
;143
(5
):694
–700
.
[PubMed]
0002-917340.
Chernesky
M
, Jang
D
, Schweizer
J
, Arias
M
, Doerwald-Munoz
L
, Gupta
M
, et al HPV E6 oncoproteins and nucleic acids in neck lymph node fine needle aspirates and oral samples from patients with oropharyngeal squamous cell carcinoma
. Papillomavirus Res
. 2018
Dec
;6
:1
–5
.
[PubMed]
2405-852141.
Day
SP
, Hudson
A
, Mast
A
, Sander
T
, Curtis
M
, Olson
S
, et al Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study
. J Clin Virol
. 2009
Jul
;45
Suppl 1
:S63
–72
.
[PubMed]
1386-653242.
Einstein
MH
, Martens
MG
, Garcia
FA
, Ferris
DG
, Mitchell
AL
, Day
SP
, et al Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology
. Gynecol Oncol
. 2010
Aug
;118
(2
):116
–22
.
[PubMed]
0090-825843.
Solomides
CC
, Bibbo
M
, Wang
ZX
. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma
. Acta Cytol
. 2012
;56
(2
):196
–8
.
[PubMed]
0001-554744.
Guo
M
, Khanna
A
, Dhillon
J
, Patel
SJ
, Feng
J
, Williams
MD
, et al Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma
. Cancer Cytopathol
. 2014
Feb
;122
(2
):96
–103
.
[PubMed]
1934-662X45.
Dockter
J
, Schroder
A
, Eaton
B
, Wang
A
, Sikhamsay
N
, Morales
L
, et al Analytical characterization of the APTIMA HPV Assay
. J Clin Virol
. 2009
Jul
;45
Suppl 1
:S39
–47
.
[PubMed]
1386-653246.
Dockter
J
, Schroder
A
, Hill
C
, Guzenski
L
, Monsonego
J
, Giachetti
C
. Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions
. J Clin Virol
. 2009
Jul
;45
Suppl 1
:S55
–61
.
[PubMed]
1386-653247.
Han
M
, Bernadt
CT
, Murray
B
, Johnson
SM
, Jalaly
JB
, Garcia
T
, et al Aptima HR-HPV testing from Diff-Quick-stained fine-needle aspiration smears of oropharyngeal squamous cell carcinoma
. J Am Soc Cytopathol
. 2016
;5
(4
):221
–6
. 2213-294548.
Schweizer
J
, Lu
PS
, Mahoney
CW
, Berard-Bergery
M
, Ho
M
, Ramasamy
V
, et al Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer
. J Clin Microbiol
. 2010
Dec
;48
(12
):4646
–8
.
[PubMed]
0095-113749.
Yu
L
, Jiang
M
, Qu
P
, Wu
Z
, Sun
P
, Xi
M
, et al Clinical evaluation of human papillomavirus 16/18 oncoprotein test for cervical cancer screening and HPV positive women triage
. Int J Cancer
. 2018
Aug
;143
(4
):813
–22
.
[PubMed]
0020-713650.
van Hamont
D
, van Ham
MA
, Bakkers
JM
, Massuger
LF
, Melchers
WJ
. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test
. J Clin Microbiol
. 2006
Sep
;44
(9
):3122
–9
.
[PubMed]
0095-113751.
Steinau
M
, Onyekwuluje
JM
, Scarbrough
MZ
, Unger
ER
, Dillner
J
, Zhou
T
. Performance of commercial reverse line blot assays for human papillomavirus genotyping
. J Clin Microbiol
. 2012
May
;50
(5
):1539
–44
.
[PubMed]
0095-113752.
Takes
RP
, Kaanders
JH
, van Herpen
CM
, Merkx
MA
, Slootweg
PJ
, Melchers
WJ
. Human papillomavirus detection in fine needle aspiration cytology of lymph node metastasis of head and neck squamous cell cancer
. J Clin Virol
. 2016
Dec
;85
:22
–6
.
[PubMed]
1386-653253.
Rollo
F
, Dona’
MG
, Pellini
R
, Pichi
B
, Marandino
F
, Covello
R
, et al Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary
. Cytopathology
. 2018
Oct
;29
(5
):449
–54
.
[PubMed]
0956-550754.
Donà
MG
, Giuliani
M
, Vocaturo
A
, Spriano
G
, Pichi
B
, Rollo
F
, et al Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma
. Cancer
. 2014
Nov
;120
(22
):3477
–84
.
[PubMed]
0008-543X55.
Chute
DJ
, Aramouni
GT
, Brainard
JA
, Hoschar
AP
, Kroeger
A
, Yen-Lieberman
B
. Hybrid Capture 2 human papilloma virus testing for head and neck cytology specimens
. J Am Soc Cytopathol
. 2014
Jul
;3
(4
):173
–82
. 2213-294556.
Hakima
L
, Adler
E
, Prystowsky
M
, Schiff
B
, Schlecht
N
, Fox
A
, et al Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas
. Diagn Cytopathol
. 2015
Sep
;43
(9
):683
–7
.
[PubMed]
8755-103957.
Lastra
RR
, Pramick
MR
, Nakashima
MO
, Weinstein
GS
, Montone
KT
. LiVolsi VA, Baloch ZW. Adequacy of fine-needle aspiration specimens for human papillomavirus infection molecular testing in head and neck squamous cell carcinoma
. Cytojournal
. 2013
;•••
:10
.1742-6413© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
